Furthermore, calcitriol supplementation induced differential dose-dependent modulation of proliferative tumour phenotypes; this was associated with significant decreases in the viability of cancer cells and the activation of two key apoptotic pathways, i.e., caspase and Bcl/Bax. The gene discussed is BAX; the disease is neoplasm.